Pure red cell aplasia associated with cytomegalovirus and Epstein-Barr virus infection in seven cases of Chinese children

Hematology

Volumn 18, Issue 1, 2013, Pages 56-59

  Xu, Lu Hong ^a   Fang, Jian Pei ^a   Weng, Wen Jun ^a   Huang, Ke ^a   Guo, Hai Xia ^a   Liu, Yong ^a   Zhang, Jin Hua ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cytomegalovirus; Epstein Barr virus; Pure red cell aplasia

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; GANCICLOVIR; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISONE;

ANEMIA; APLASIA; ARTICLE; BLOOD CELL COUNT; BLOOD TRANSFUSION; CHILD; CHINESE; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DRUG MEGADOSE; EPSTEIN BARR VIRUS INFECTION; ERYTHROBLAST; FEMALE; HUMAN; HUMAN TISSUE; INFANT; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; MALE; PALLOR; PRESCHOOL CHILD; PRIORITY JOURNAL; PURE RED CELL ANEMIA; RETICULOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE;

BLOOD TRANSFUSION; CHILD, PRESCHOOL; CHINA; CYCLOSPORINE; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; METHYLPREDNISOLONE; RED-CELL APLASIA, PURE;

EID: 84873487300     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/1607845412Y.0000000044     Document Type: Article

References (20)

1. Dessypris EN. The biology of pure red cell aplasia. Semin Hematol. 1991;28:275-84.
2. Thompson CA, Steensma DP. Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience. Br J Haematol. 2006;135:405-7.
3. Hirokawa M, Sawada K, Fujishima N, Kawano F, Kimura A, Watanabe T, et al. Acquired pure red cell aplasia associated with malignant lymphomas: a nationwide cohort study in Japan for the PRCA Collaborative Study Group. Am J Hematol. 2009;84:144-8.
4. Atzeni F, Sarzi-Puttini P, Capsoni F, Vulpio L, Carrabba M. Successful treatment of pure red cell aplasia in systemic lupus erythematosus with cyclosporin A. Clin Exp Rheumatol. 2003; 21:759-62.
5. Vlachos A, Ball S, Dahl N, Alter BP, Sheth S, Ramenghi U, et al. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br J Haematol. 2008;142:859-76.
6. Marmont AM. Therapy of pure red cell aplasia. Semin Hematol. 1991;28:285-97.
7. Dinçol G, Aktan M, Nalçaci M, Yavuz AS, Keskin H, Dawson B, et al. Clonality of acquired primary pure red cell aplasia: effectiveness of antithymocyte globulin. Leuk Lymphoma. 2001;42:1413-7.
8. Choi BG, Yoo WH. Successful treatment of pure red cell aplasia with plasmapheresis in a patient with systemic lupus erythematosus. Yonsei Med J. 2002;43:274-8.
9. Brown KE, Young NS. Parvoviruses and bone marrow failure. Stem Cells. 1996;14:151-63.
10. Mrzljak A, Kardum-Skelin I, Cvrlje VC, Kanizaj TF, Sustercić D, Gustin D, et al. Parvovirus B 19 (PVB19) induced pure red cell aplasia (PRCA) in immunocompromised patient after liver transplantation. Coll Antropol. 2010;34:271-4.
11. Charles RJ, Sabo KM, Kidd PG, Abkowitz JL. The pathophysiology of pure red cell aplasia: implications for therapy. Blood. 1996;87:4831-8.
12. al-Awami Y, Sears DA, Carrum G, Udden MM, Alter BP, Conlon CL. Pure red cell aplasia associated with hepatitis C infection. Am J Med Sci. 1997;314:113-7.
13. Socinski MA, Ershler WB, Tosato G, Blaese RM. Pure red blood cell aplasia associated with chronic Epstein-Barr virus infection: evidence for T cell-mediated suppression of erythroid colony forming units. J Lab Clin Med. 1984;104:995-1006.
14. Togashi J, Sugawara Y, Hashimoto M, Tamura S, Kaneko J, Aoki T, et al. Oral valganciclovir versus intravenous ganciclovir as preemptive treatment for cytomegalovirus infection after living donor liver transplantation: a randomized trial. Biosci Trends. 2011;5:217-22.
15. Humar A, Hébert D, Davies HD, Humar A, Stephens D, O'Doherty B, et al. A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein--Barr virus related posttransplant lymphoproliferative disorder. Transplantation. 2006;81:856-61.
16. Sawada K, Hirokawa M, Fujishima N. Diagnosis and management of acquired pure red cell aplasia. Hematol Oncol Clin North Am. 2009;23:249-59.
17. Kwong YL, Wong KF, Liang RH, Chu YC, Chan LC, Chan TK. Pure red cell aplasia: clinical features and treatment results in 16 cases. Ann Hematol. 1996;72:137-40.
18. Sawada K, Fujishima N, Hirokawa M. Acquired pure red cell aplasia: updated review of treatment. Br J Haematol. 2008;142: 505-14.
19. Müller BU, Tichelli A, Passweg JR, Nissen C, Wodnar-Filipowicz A, Gratwohl A. Successful treatment of refractory acquired pure red cell aplasia (PRCA) by allogeneic bone marrow transplantation. Bone Marrow Transplant. 1999;23: 1205-7.
20. Tseng SB, Lin SF, Chang CS, Liu TC, Hsiao HH, Liu YC, et al. Successful treatment of acquired pure red cell aplasia (PRCA) by allogeneic peripheral blood stem cell transplantation. Am J Hematol. 2003;74:273-5.